FGFR4 and breast cancer: A recent study found that breast cancer cell lines can express FGFR4 to gain the ability to resist apoptosis when treated with cyclophosphamide and doxorubicin, while this capacity disappears when the FGFR4 gene is silenced (Andre and Cortes, 2015).